Technologies relating to Chinese medicine composition used for treatment of protecting respiratory tract from viral infection by significantly increasing immunity of patients are disclosed. An example composition used for treatment of protecting respiratory tract from viral infection by significantly increasing immunity of a patient, includes: an Astragalus Root; a Ganoderma Spore; a Siberian Ginseng; an Underleaf Pearl; a Honeysuckle Flower; a Chinese Globe Flower; an Isatis Leaf; an Woad Root; a Patchouli; a Forsythia Fruit; an asiatic Pennywort; an Aged Tangerine Peel; a Giant Knotweed; a Reed Rhizome; an Unprepared Licorice Root; and a Fresh Ginger Rhizome.

Technologies relating to Chinese medicine composition used for treatment of protecting respiratory tract from viral infection by significantly increasing immunity of patients are disclosed. An example composition used for treatment of protecting respiratory tract from viral infection by significantly increasing immunity of a patient, includes: an Astragalus Root; a Ganoderma Spore; a Siberian Ginseng; an Underleaf Pearl; a Honeysuckle Flower; a Chinese Globe Flower; an Isatis Leaf; an Woad Root; a Patchouli; a Forsythia Fruit; an asiatic Pennywort; an Aged Tangerine Peel; a Giant Knotweed; a Reed Rhizome; an Unprepared Licorice Root; and a Fresh Ginger Rhizome.

Technologies relating to Chinese medicine composition used for treatment of protecting respiratory tract from viral infection by significantly increasing immunity of patients are disclosed. An example composition used for treatment of protecting respiratory tract from viral infection by significantly increasing immunity of a patient, includes: an Astragalus Root; a Ganoderma Spore; a Siberian Ginseng; an Underleaf Pearl; a Honeysuckle Flower; a Chinese Globe Flower; an Isatis Leaf; an Woad Root; a Patchouli; a Forsythia Fruit; an asiatic Pennywort; an Aged Tangerine Peel; a Giant Knotweed; a Reed Rhizome; an Unprepared Licorice Root; and a Fresh Ginger Rhizome.

A method for decreasing formation of one or more chemiexcitation-induced dark cyclobutane pyrimidine dimers (dCPDs) in a cell or DNA molecule in a subject, who has been exposed to UV radiation, is provided. The method comprises administering to the subject an effective amount of a dCPD quencher within 8 hours after the exposure. The dCPD quencher is selected from the group consisting of ellagic acid, Porphyra Umbilicalis Extract (including Porphyra Umbilicalis Extract (and) Sodium Lactate (and) Lecithin), mycosporine-like amino acids (MAAs) and synthetic analogues thereof, Scutellaria Baicalensis Root Extract, Chrysanthemum Morifolium Leaf Extract, ferulic acid, fused-ring cyanoacrylates, curcumin, epigallocatechin gallate, Scutellaria Baicalensis Root Extract (and) Acacia Catechu Wood Extract, sorbic acid, Polygonum Cuspidatum Root Extract, Acacia Catechu Extract, dipicolinic acid, squalene, Lonicera Japonica (Honeysuckle) Flower Extract, beta-carotene and combinations thereof. The dCPD quencher may be administered to the subject in the absence of UV radiation.

A method for decreasing formation of one or more chemiexcitation-induced dark cyclobutane pyrimidine dimers (dCPDs) in a cell or DNA molecule in a subject, who has been exposed to UV radiation, is provided. The method comprises administering to the subject an effective amount of a dCPD quencher within 8 hours after the exposure. The dCPD quencher is selected from the group consisting of ellagic acid, Porphyra Umbilicalis Extract (including Porphyra Umbilicalis Extract (and) Sodium Lactate (and) Lecithin), mycosporine-like amino acids (MAAs) and synthetic analogues thereof, Scutellaria Baicalensis Root Extract, Chrysanthemum Morifolium Leaf Extract, ferulic acid, fused-ring cyanoacrylates, curcumin, epigallocatechin gallate, Scutellaria Baicalensis Root Extract (and) Acacia Catechu Wood Extract, sorbic acid, Polygonum Cuspidatum Root Extract, Acacia Catechu Extract, dipicolinic acid, squalene, Lonicera Japonica (Honeysuckle) Flower Extract, beta-carotene and combinations thereof. The dCPD quencher may be administered to the subject in the absence of UV radiation.

A method for treating skin of a person is disclosed. The method can include topically applying to the skin of the person a composition comprising an effective amount of an aqueous, alcoholic, or aqueous-alcoholic extract from Chamaecrista mimosoides, wherein the composition reduces tyrosinase activity in the skin, increases antioxidant activity in the skin, and/or increases skin moisture content.

A method for treating skin of a person is disclosed. The method can include topically applying to the skin of the person a composition comprising an effective amount of an aqueous, alcoholic, or aqueous-alcoholic extract from Chamaecrista mimosoides, wherein the composition reduces tyrosinase activity in the skin, increases antioxidant activity in the skin, and/or increases skin moisture content.

A method for treating skin of a person is disclosed. The method can include topically applying to the skin of the person a composition comprising an effective amount of an aqueous, alcoholic, or aqueous-alcoholic extract from Chamaecrista mimosoides, wherein the composition reduces tyrosinase activity in the skin, increases antioxidant activity in the skin, and/or increases skin moisture content.

A topical skin composition is disclosed. The topical skin composition can include a Bougainvillea glabra extract, hyaluronic acid, glycerin, tocopherol, phenoxyethanol, sodium hydroxide, and ethylhexylglycerin.

A topical skin composition is disclosed. The topical skin composition can include a Bougainvillea glabra extract, hyaluronic acid, glycerin, tocopherol, phenoxyethanol, sodium hydroxide, and ethylhexylglycerin.